Home › Diffuse Large B-Cell Lymphoma › Oregon › Portland

Pag-aaral pangklinika para sa Diffuse Large B-Cell Lymphoma sa Portland, OR

Isang pag-aaral para sa Diffuse Large B-Cell Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Portland. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

Nagre-recruitPhase 2

Oregon Health and Science University, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06500273

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Nagre-recruitPhase 2

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06649812

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Nagre-recruitPhase 3

Kaiser Permanente Interstate Medical Office - Central ( Site 0181), Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06717347

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

Nagre-recruitPhase 2

Providence Portland Medical Center ( Site 0120), Portland
Providence Oncology and Hematology Clinic Westside ( Site 0179), Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06890884

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

Nagre-recruitObservasyonal na pag-aaral

OHSU Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06784167

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

Nagre-recruitPhase 1

Oregon Health & Science University (OHSU), Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07226843

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Oregon Health and Science University ( Site 1004), Portland

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

Nagre-recruitPhase 2

Providence Portland Medical Center, Portland
Providence St. Vincent Medical Center, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06806033

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Nagre-recruitPhase 1/2

Oregon Health & Science University, Portland

Edad 13 hanggang 90 · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT06533579

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

Nagre-recruitObservasyonal na pag-aaral

Oregon Health and Science University Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 5, 2026 · NCT06116110

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

Oregon Health and Science University Knight Cancer Institute, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Mosunetuzumab With Chemotherapy for the Treatment of Patients With Untreated C-Myc Rearrangement Positive High Grade B Cell Lymphoma or Diffuse Large B Cell Lymphoma

Nagre-recruitPhase 1/2

OHSU Knight Cancer Institute, Portland

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT06249191

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Nagre-recruitPhase 2

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland
Oregon Health and Science University, Portland
at 1 pa

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 2, 2026 · NCT05633615

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Nagre-recruitPhase 2

Providence Portland Medical Center, Portland
Providence Saint Vincent Medical Center, Portland
Providence Willamette Falls Medical Center, Oregon City · 12 mi ang layo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT05890352

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Nagre-recruitPhase 1

Oregon Health & Science University, Portland

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2025 · NCT05780034

Pag-aaral para sa Diffuse Large B-Cell Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Portland

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.